{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:29:29Z","timestamp":1785281369179,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","joms.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.joms.2020.02.016","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T03:46:39Z","timestamp":1582256799000},"page":"1190.e1-1190.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["What Are the Most Commonly Reported Complications With Cosmetic Botulinum Toxin Type A Treatments?"],"prefix":"10.1016","volume":"78","author":[{"given":"Kevin C.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander B.","family":"Pascal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6141-6371","authenticated-orcid":false,"given":"Steven","family":"Halepas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alia","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.joms.2020.02.016_bib1","article-title":"Historical perspectives and guidelines for botulinum neurotoxin subtype nomenclature","volume":"9:e1","author":"Peck","year":"2017","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.joms.2020.02.016_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ajog.2006.03.108","article-title":"Botulinum toxin: From life-threatening disease to novel medical therapy","volume":"196","author":"Mahajan","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.joms.2020.02.016_bib5","doi-asserted-by":"crossref","first-page":"686329","DOI":"10.1155\/2013\/686329","article-title":"Efficacy of onabotulinumtoxinA (Botox) versus abobotulinumtoxinA (Dysport) using a conversion factor (1:2.5) in the treatment of primary palmar hyperhidrosis","volume":"2013","author":"El Kahky","year":"2013","journal-title":"Dermatol Res Pract"},{"issue":"suppl 1","key":"10.1016\/j.joms.2020.02.016_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1468-1331.2006.01439.x","article-title":"Immunological aspects of Botox, Dysport and Myobloc\/NeuroBloc","volume":"13","author":"Dressler","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.joms.2020.02.016_bib7","author":"Rzany"},{"key":"10.1016\/j.joms.2020.02.016_bib8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1053\/joms.2003.50069","article-title":"Botulinum toxin A: A review of 1,085 oral and maxillofacial patient treatments","volume":"61","author":"Niamtu","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2020.02.016_bib9","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jaad.2005.06.011","article-title":"Botulinum toxin type A injections: Adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases","volume":"53","author":"Cot\u00e9","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.joms.2020.02.016_bib10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.joms.2019.08.003","article-title":"Complications and litigation associated with injectable facial fillers: A cross sectional study","volume":"78","author":"Beauvais","year":"2020","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2020.02.016_bib11","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1001\/jamafacial.2017.2242","article-title":"Adverse events in facial implant surgery and associated malpractice litigation","volume":"20","author":"Rayess","year":"2018","journal-title":"JAMA Facial Plast Surg"},{"key":"10.1016\/j.joms.2020.02.016_bib12","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/dsu.12188","article-title":"Analysis of botulinum toxin products and litigation in the United States","volume":"39","author":"Korman","year":"2013","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.joms.2020.02.016_bib13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/0748806819827408","article-title":"Analysis of factors associated with malpractice litigation in rhinoplasty","volume":"36","author":"Raggio","year":"2019","journal-title":"Am J Cosmetic Surg"},{"key":"10.1016\/j.joms.2020.02.016_bib14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/jamafacial.2016.1782","article-title":"Analysis of factors associated with rhytidectomy malpractice litigation cases","volume":"19","author":"Kandinov","year":"2017","journal-title":"JAMA Facial Plast Surg"},{"key":"10.1016\/j.joms.2020.02.016_bib15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1001\/jamafacial.2017.1888","article-title":"A cross-sectional analysis of adverse events and litigation for injectable fillers","volume":"20","author":"Rayess","year":"2018","journal-title":"JAMA Facial Plast Surg"},{"key":"10.1016\/j.joms.2020.02.016_bib16","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/dsu.12463","article-title":"Safety of botulinum toxin A in aesthetic treatments: A systematic review of clinical studies","volume":"40","author":"Cavallini","year":"2014","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.joms.2020.02.016_bib17","first-page":"227","article-title":"Botulinum toxin type A products are not interchangeable: A review of the evidence","volume":"8","author":"Brin","year":"2014","journal-title":"Biologics"},{"key":"10.1016\/j.joms.2020.02.016_bib18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.fsc.2006.10.004","article-title":"Complications of botulinum toxin type A","volume":"15","author":"Carruthers","year":"2007","journal-title":"Facial Plast Surg Clin North Am"},{"key":"10.1016\/j.joms.2020.02.016_bib19","doi-asserted-by":"crossref","first-page":"310e","DOI":"10.1097\/PRS.0000000000001544","article-title":"Efficacy and safety of botulinum toxin type A in the treatment of glabellar lines: A meta-analysis of randomized, placebo-controlled, double-blind trials","volume":"136","author":"Guo","year":"2015","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.joms.2020.02.016_bib20","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jaad.2009.06.040","article-title":"Safety and tolerability of onabotulinumtoxinA in the treatment of facial lines: A meta-analysis of individual patient data from global clinical registration studies in 1678 participants","volume":"61","author":"Brin","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.joms.2020.02.016_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxicon.2011.04.019","article-title":"Flu-like symptoms following botulinum toxin therapy","volume":"58","author":"Baizabal-Carvallo","year":"2011","journal-title":"Toxicon"},{"issue":"suppl 4","key":"10.1016\/j.joms.2020.02.016_bib22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1468-1331.2006.01652.x","article-title":"Safety and efficacy of botulinum toxin type A following long-term use","volume":"13","author":"Naumann","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.joms.2020.02.016_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.det.2013.09.009","article-title":"Aesthetic uses of the botulinum toxin","volume":"32","author":"Dorizas","year":"2014","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.joms.2020.02.016_bib24","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00702-012-0893-9","article-title":"Immunogenicity of botulinum toxins","volume":"120","author":"Naumann","year":"2013","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.joms.2020.02.016_bib25","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1177\/1090820X14532648","article-title":"The first case report of a systemic allergy to onabotulinumtoxinA (Botox) in a healthy patient","volume":"34","author":"Rosenfield","year":"2014","journal-title":"Aesthet Surg J"},{"key":"10.1016\/j.joms.2020.02.016_bib26","doi-asserted-by":"crossref","first-page":"NP102","DOI":"10.1093\/asj\/sju105","article-title":"Report of allergic reaction after application of botulinum toxin","volume":"35","author":"Careta","year":"2015","journal-title":"Aesthet Surg J"},{"key":"10.1016\/j.joms.2020.02.016_bib27","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1520\/JFS2004196","article-title":"Fatal case of Botox-related anaphylaxis?","volume":"50","author":"Li","year":"2005","journal-title":"J Forensic Sci"},{"key":"10.1016\/j.joms.2020.02.016_bib28","series-title":"Botox (onabotulinumtoxinA) for injection, for intramuscular, intradetrusor, or intradermal use","author":"Food and Drug Administration","year":"2019"},{"key":"10.1016\/j.joms.2020.02.016_bib29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5992\/AJCS-D-12-00028.1","article-title":"Review of facial fillers and injectable neurotoxins","volume":"30","author":"Ferneini","year":"2013","journal-title":"Am J Cosmet Surg"},{"key":"10.1016\/j.joms.2020.02.016_bib30","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1007\/s00415-018-8934-4","article-title":"A strategy for managing flu-like symptoms after botulinum toxin injections","volume":"265","author":"George","year":"2018","journal-title":"J Neurol"}],"container-title":["Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239120302068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239120302068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T17:00:44Z","timestamp":1759510844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278239120302068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0278239120302068"],"URL":"https:\/\/doi.org\/10.1016\/j.joms.2020.02.016","relation":{},"ISSN":["0278-2391"],"issn-type":[{"value":"0278-2391","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What Are the Most Commonly Reported Complications With Cosmetic Botulinum Toxin Type A Treatments?","name":"articletitle","label":"Article Title"},{"value":"Journal of Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joms.2020.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Association of Oral and Maxillofacial Surgeons","name":"copyright","label":"Copyright"}]}}